What Drives Drug Pricing?
461 views · Published 24 June 2017 · 1:02:53 · Indexed 1 November 2026
Channel: The Aspen Institute · 2017 · News & Politics
High drug prices have seized headlines, angered patient advocates, and prompted congressional hearings. Many causes have been suggested — among them, a fragmented pharmaceutical market that limits competition, the quest for profits (whether to fund expensive R&D or otherwise), and government regulations that bar Medicare from negotiating prices. Harder to find are solutions for patients who cannot afford their therapies. Venture capitalists may be a unique leverage point on the system because their investments can encourage risk-taking and the development of novel, high-impact medicines, shifting the locus of industry’s search for rewards. How do we encourage a drug-development system that innovates, while keeping lifesaving therapies affordable? Steve Clemons, Moderator Gregory Glover Anula Jayasuriya Aaron Kesselheim
More from this channel
-
5:31
In Conversation w/Karl Rove. Moderator Walter Isaacson, 2006
-
7:22
Can the US Still Afford to be a Nation of Immigrants? (2006)
-
4:32
A Conversation with Lance Armstrong (2007)
-
3:49
Senator Arlen Specter on the Big Idea of Stem Cell Research
-
5:18
A Talk with Israeli Ambassador to the US Sallai Meridor
-
4:52
Americans and Their Foreign Policy (2007)
-
8:53
The Iraq Question II (2007)
-
3:38
America and the Global Economy: A Briefing for the Next Pres